Skip to main content
. Author manuscript; available in PMC: 2015 Dec 1.
Published in final edited form as: Am J Surg Pathol. 2014 Dec;38(12):1618–1626. doi: 10.1097/PAS.0000000000000283

TABLE 1.

Demographics and Follow-up of JPS Patients (n = 41)

Patients With Upper GI Tract Biopsies (n = 22)

Patients Without Upper GI
Tract Biopsies (n = 19)
Without Upper JP
(n = 9)
With Upper JP
(n = 13)
Sex (male, female) 8, 11 4, 5 4, 9
Race (white, black, other) 13, 4, 2 8, 1, 0 12, 1, 0
Family history (yes, no, unknown) 7, 5, 7 4, 4, 1 8, 1, 4
Gene mutation Unknown Unknown 2 patients with SMAD4 mutation
Total colectomy 9 5 6
Total gastrectomy 0 0 3
GI tract Adenocarcinoma 1 colorectum 0 1 stomach
Death 1 0 3
Age at first pathology specimen (y) 11.7 (2.5–33) 12.0 (3–26) 30.5 (4–68)
Age at last pathology specimen (y) 14.6 (4–35) 15.4 (8–27) 38.2 (7–73)
Pathology follow-up/patient (mo) 31.3 (1–96) 36.6 (5–97) 93.5 (4–171)
No. upper endoscopies/patient (average, range) 2 patients had normal EGD without biopsy 1.2 (1–2) 4.5 (1–12)
Age at first EGD specimen (y) NA 13.4 (4–26) 31.5 (6–73)
Age at last EGD specimen (y) NA 13.8 (6–26) 37.5 (7–73)
EGD follow-up/patient (mo) NA 3.9 (1–17) 73.2 (1–150)
Age at first upper JP diagnosis (y) NA NA 33.4 (7–73)

Data shown in the table are average and range.